FDA probe of Abbott facility finds quality control issues

An inspection at the Abbott Laboratories facility in Sturgis, Michigan found a harmful bacteria called Cronobacter sakazakii on the surface of some areas producing its powdered baby formula, the U.S. health regulator said on Tuesday.

Complaints that the facility’s products had caused bacterial infections forced Abbott to recall certain Alimentum, Similac and EleCare baby formulas last month, prompting a probe from the U.S. Food and Drug Administration (FDA).

The inspection from Jan. 31 to March 18 showed https://www.fda.gov/media/157073/download?utm_medium=email&utm_source=govdelivery that Abbott did not have a control system covering all stages of processing to prevent microbe contamination of infant formula.

Personnel working with infant formula also did not wear necessary protective apparel, the FDA said.

“We’re taking this very seriously and are working closely with the FDA to implement corrective actions,” Abbott said in a statement.

No Cronobacter sakazakii was found during the company’s testing of products that were distributed to consumers, Abbott added.

The company also said that the genetic makeup of the Cronobacter sakazakii found at the Michigan plant did not match that of the reported cases.

Cronobacter sakazakii bacteria can cause serious invasive infections and premature infant death.

  • Related Posts

    Maha cops bust three factories, seize drugs worth Rs 56 crore in Bengaluru

    The Konkan division of Maharashtra ANTF raided three different locations in Bengaluru, during which the drug manufacturing units were busted. BENGALURU:  While the state government is aiming to make Karnataka…

    ‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

    New Delhi: A pharma group has sought extension for those production units that have already submitted upgradation plans and can demonstrate execution progress, even as the drug regulatory authority seems…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Maha cops bust three factories, seize drugs worth Rs 56 crore in Bengaluru

    Maha cops bust three factories, seize drugs worth Rs 56 crore in Bengaluru

    ‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

    ‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

    Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

    Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

    National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

    National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

    Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

    Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

    Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

    Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US